(Critical Path Institute (C-Path)) C-Path's Critical Path to TB Drug Regimens (CPTR) has been awarded a $1.1 million grant from the Bill & Melinda Gates Foundation. With it, CPTR will partner with Translational Genomics Research Institute's Pathogen Genomics Division (TGen North) to sequence thousands of TB bacteria isolates from around the globe, to better understand the genetic basis of drug-resistant TB and to enrich CPTR's Relational Sequencing TB Data Platform (ReSeqTB).
from EurekAlert! - Social and Behavioral Science http://ift.tt/2pTLjDU
No comments:
Post a Comment